Selective down regulation of vascular beta 1 adrenergic receptors after prolonged isoproterenol infusion

Area of Science:

• Pharmacology
• Cardiovascular Physiology
• Adrenergic Receptor Research

Background:

• Prolonged isoproterenol infusion reduces cardiac and vascular beta-adrenergic receptor sensitivity.
• Previous studies indicated no change in alpha 1 agonist or phosphodiesterase inhibitor responsiveness.
• The current study investigates differential down-regulation of vascular beta-1 and beta-2 adrenergic receptors.

Purpose of the Study:

• To determine if beta-1 and beta-2 vascular receptors exhibit similar down-regulation following prolonged isoproterenol infusion.
• To compare the susceptibility of beta-1 versus beta-2 adrenergic receptors to desensitization in vascular tissue.
• To explore the implications for congestive heart failure therapy and beta-agonist mechanisms.

Main Methods:

• Utilized rat jugular vein preparation for assessing vascular smooth muscle relaxation.
• Administered prolonged isoproterenol infusion (400 µg/kg/h for 4 days) to experimental rats.
• Compared responses to isoproterenol (beta-2 mediated) and norepinephrine (beta-1 mediated) in infused versus saline-treated rats.

Main Results:

• Isoproterenol-induced relaxation was reduced approximately threefold in tissues from isoproterenol-infused rats compared to controls.
• Norepinephrine-induced relaxation in jugular veins was virtually abolished in isoproterenol-infused rats relative to saline-treated animals.
• Demonstrated differential down-regulation, with beta-1 receptors being significantly more affected than beta-2 receptors.

Conclusions:

• Vascular beta-1 adrenergic receptors are considerably more susceptible to down-regulation than beta-2 adrenergic receptors.
• This differential sensitivity may be crucial for understanding congestive heart failure treatment strategies.
• Provides insights into the mechanisms underlying the inotropic effects of beta receptor agonists.